News tagged with tumor marker
Giving research a boost with cheaper biochips
An EPFL invention has drastically reduced the cost of producing biochips, which are used to measure glucose and drug levels in the blood and to detect biomolecules and cellular signals. This development could ...
Mar 14, 2012 |
5 / 5 (1) |
0
|
Breakthroughs help brain surgeons remove nearly all of a tumor, raise survival rates
Donna Vinson suddenly felt she "couldn't think well." She was far off from choosing the right words, even pointing to a garbage can once as she asked a family member to pass the potatoes.
Apr 18, 2011 |
5 / 5 (2) |
0
Circulating tumor cells predicted recurrence, death in patients with early-stage breast cancer
The presence of one to four circulating tumor cells (CTCs) in the blood of early-stage breast cancer patients almost doubled patient's risk of cancer relapse and death, and five or more CTCs increased recurrence by 400 percent ...
Dec 10, 2010 |
5 / 5 (1) |
0
The evolution of melanoma diagnosis: 25 years beyond the ABCDs
Twenty-five years after publishing the mnemonic "ABCD" to facilitate the early diagnosis of melanoma, the group who came up with that moniker says early detection remains a key factor in lowering mortality from malignant ...
Jul 29, 2010 |
5 / 5 (1) |
0
New diagnostic test for bladder cancer
Researchers from the Danish Cancer Society and the Herlev University Hospital of Copenhagen have developed a novel assay to test for multiple tumor markers in bladder cancer. The related report by Serizawa et al, "Custom-designed ...
Jun 25, 2010 |
not rated yet |
0
Molecular marker could help spot pancreatic cancer early
Researchers at the University of North Carolina at Chapel Hill School of Medicine have identified a molecular marker of pancreatic cancer that may help spot the disease at its earliest stages, when it can ...
Apr 26, 2010 |
not rated yet |
0
Stanford scientists find new marker to identify severe breast cancer cases
Women with breast cancer whose tumors express high levels of a particular genetic marker are significantly more likely to die from their disease than are those with more normal levels, according to researchers at Stanford ...
Apr 14, 2010 |
not rated yet |
0
|
Detecting cancer early
A new testing method is being developed to detect cancer soon after the tumor has formed. It will identify characteristic substances in the blood which accompany a certain type of tumor. The first steps in ...
Nanotechnology / Bio & Medicine
Feb 01, 2010 |
4 / 5 (1) |
0
Why don't brain tumors respond to medication?
Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide ...
Sep 01, 2009 |
5 / 5 (1) |
0
Implantable Device Offers Continuous Cancer Monitoring
(PhysOrg.com) -- Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but offer only a snapshot of the tumor at a single moment in time.
Nanotechnology / Bio & Medicine
Jul 21, 2009 |
5 / 5 (3) |
1
Research uncovers clues to virus-cancer link
In a series of recently-published articles, a research team from the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center has uncovered clues to the development of cancers in AIDS patients.
Jun 17, 2009 |
not rated yet |
1
Genetic marker may predict early onset of prostate cancer
Fox Chase Cancer Center researchers have identified a genetic marker that is associated with an earlier onset of prostate cancer in Caucasian men who have a family history of prostate cancer. If the data are confirmed, the ...
May 15, 2009 |
5 / 5 (1) |
0
Older men more likely than women to die after pneumonia
Differing biological response to infection between men and women may explain higher death rates among older men who are hospitalized with community-acquired pneumonia (CAP). The findings, published online in the Critical Ca ...
Medicine & Health / Diseases, Conditions, Syndromes
Apr 29, 2009 |
4 / 5 (1) |
0
New tumor markers determine therapy intensity
Characteristic changes in the DNA of medulloblastoma, the most frequent malignant brain tumor in childhood, indicate precisely how aggressively the tumor will continue to spread and what the chances of disease relapse are. ...
Mar 17, 2009 |
not rated yet |
0
